GSK3B and Alzheimer disease: In contrast to the AD group, PhM and concurrent administration of MH or ZC with AlCl3 dramatically reduce GSK3β signaling by downregulating GSK3β mRNA expressions by 38%, 62%, and 69%, respectively.